Women’s health diagnostics remain one of the most underserved areas in healthcare. Too often, women face delayed diagnoses, ineffective treatments, and repeated clinical visits before receiving clear answers.
Despite the significant health and economic burden associated with gynecological conditions, investment and innovation in women’s health diagnostics have lagged behind other areas of medicine.
Estimated annual economic burden of menopause and gynecological conditions 1
Women report experiencing a misdiagnosis for a gynecological or female-specific condition 2
Share of healthcare venture funding allocated to women’s health startups 3
Creating the best consumer testing experience means ensuring Detect meets the bar for PCR-level lab accuracy, with clinically validated results.
Typical lab-based PCR tests require at least 24 hours—and sometimes several days—to receive results. We’re working on a test that requires no lab work, with results available in 1 hour.
Our test is designed to be comfortable and easy to use—from swabbing your nostril to getting your result—wherever and whenever you want to take a test. There’s nothing to mail, and no waiting days to receive results.
With our proprietary chemistry built into the Detect Cap, we’re building our platform to be both robust to the development of new SARS-CoV-2 variants and easy to adapt to new pathogens in the future.
We plan to deliver millions of tests by Q2 2021, and tens of millions per month later in 2021.
Molecular tests—like Detect and PCR lab tests—look for virus RNA (the genetic material). They are able to identify even small amounts of the virus because of a process known as “amplification,” which replicates snippets of RNA to make them much easier to find. This process helps detect the virus days before symptoms occur, and at the tail-end of infection. Antigen tests only look for proteins on the outside of the virus and don’t use amplification, so they have a higher risk of missing infection at those stages.
Pending FDA Emergency Use Authorization
Molecular tests—like Detect and PCR lab tests—look for the RNA (the genetic code) of the virus itself. These tests are the standard for accuracy and may detect infections in people before they have symptoms. They can also be easily reconfigured to detect new strains of the virus as it mutates.
.png)
Detect combines a nucleic acid test with lateral flow hardware that can be manufactured at scale. We're building a platform anyone can use to test for any pathogen on a regular basis, starting with Covid-19.
